{"title":"Conditioned Medium of BMSCs Alleviates H<sub>2</sub>O<sub>2</sub>-Induced Oxidative Damage in PC12 Cells Through the LDLR Pathway.","authors":"MingDong Li, Zhongquan Fu, Xing Gao, Yuchen Zhang, Zengxin Gao","doi":"10.1007/s12035-025-04804-w","DOIUrl":null,"url":null,"abstract":"<p><p>Oxidative damage is pivotal in the pathogenesis and progression of a myriad of neurological disorders. The current study was designed to elucidate the therapeutic potential of conditioned medium from bone marrow-derived mesenchymal stromal cells (BMSC-CM) and to delineate the underlying mechanisms, using a neuronal oxidative injury model for this purpose. Rat pheochromocytoma PC12 cells were exposed to H<sub>2</sub>O<sub>2</sub> to establish an oxidative injury model, followed by treatment with BMSC-CM or co-cultivation with BMSCs in a transwell apparatus. The oxidative stress levels pre- and post-intervention or co-cultivation were quantitatively assessed by PCR and western blot analyses. Furthermore, transcriptomic and bioinformatic analyses were used to identify pivotal genes and signaling pathways implicated in the observed effects. Both BMSC-CM treatment and BMSC co-culture decreased oxidative damage and inhibited apoptosis in PC12 cells. Transcriptomic data and enrichment analysis revealed 106 differentially expressed genes between BMSC-CM untreated and treated H<sub>2</sub>O<sub>2</sub>-exposed PC12 cells, including 67 downregulated and 39 upregulated genes. Notably, the significantly differentially expressed genes were predominantly those involved in lipid metabolism pathways, and the low-density lipoprotein receptor (LDLR) emerged as one statistically significant upregulated gene. The proprotein convertase subtilisin/kexin type 9, a specific inhibitor of LDLR, attenuated the positive effects of BMSC-CM treatment, corroborating that LDLR activation plays a crucial role in mitigating neuronal oxidative damage. The results of this investigation underscore the neuroprotective capacity of BMSC-CM, which we show is mediated through its ability to module lipid metabolism in neuronal cells via the LDLR. Further research into the neuroprotective properties of BMSC-CM could lead to the development of promising therapeutic avenues for neurological diseases characterized by oxidative stress.</p>","PeriodicalId":18762,"journal":{"name":"Molecular Neurobiology","volume":" ","pages":"8857-8867"},"PeriodicalIF":4.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12035-025-04804-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Oxidative damage is pivotal in the pathogenesis and progression of a myriad of neurological disorders. The current study was designed to elucidate the therapeutic potential of conditioned medium from bone marrow-derived mesenchymal stromal cells (BMSC-CM) and to delineate the underlying mechanisms, using a neuronal oxidative injury model for this purpose. Rat pheochromocytoma PC12 cells were exposed to H2O2 to establish an oxidative injury model, followed by treatment with BMSC-CM or co-cultivation with BMSCs in a transwell apparatus. The oxidative stress levels pre- and post-intervention or co-cultivation were quantitatively assessed by PCR and western blot analyses. Furthermore, transcriptomic and bioinformatic analyses were used to identify pivotal genes and signaling pathways implicated in the observed effects. Both BMSC-CM treatment and BMSC co-culture decreased oxidative damage and inhibited apoptosis in PC12 cells. Transcriptomic data and enrichment analysis revealed 106 differentially expressed genes between BMSC-CM untreated and treated H2O2-exposed PC12 cells, including 67 downregulated and 39 upregulated genes. Notably, the significantly differentially expressed genes were predominantly those involved in lipid metabolism pathways, and the low-density lipoprotein receptor (LDLR) emerged as one statistically significant upregulated gene. The proprotein convertase subtilisin/kexin type 9, a specific inhibitor of LDLR, attenuated the positive effects of BMSC-CM treatment, corroborating that LDLR activation plays a crucial role in mitigating neuronal oxidative damage. The results of this investigation underscore the neuroprotective capacity of BMSC-CM, which we show is mediated through its ability to module lipid metabolism in neuronal cells via the LDLR. Further research into the neuroprotective properties of BMSC-CM could lead to the development of promising therapeutic avenues for neurological diseases characterized by oxidative stress.
期刊介绍:
Molecular Neurobiology is an exciting journal for neuroscientists needing to stay in close touch with progress at the forefront of molecular brain research today. It is an especially important periodical for graduate students and "postdocs," specifically designed to synthesize and critically assess research trends for all neuroscientists hoping to stay active at the cutting edge of this dramatically developing area. This journal has proven to be crucial in departmental libraries, serving as essential reading for every committed neuroscientist who is striving to keep abreast of all rapid developments in a forefront field. Most recent significant advances in experimental and clinical neuroscience have been occurring at the molecular level. Until now, there has been no journal devoted to looking closely at this fragmented literature in a critical, coherent fashion. Each submission is thoroughly analyzed by scientists and clinicians internationally renowned for their special competence in the areas treated.